arginine has been researched along with paromomycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Detering, C; Varani, G | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hinnebusch, AG; Sattlegger, E | 1 |
Borkow, G; Kalinkovich, A; Lapidot, A; Lara, HH; Vijayabaskar, V | 1 |
James, TL; Lapidot, A; Litovchick, A; Vijayabaskar, V; Yu, J | 1 |
1 review(s) available for arginine and paromomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for arginine and paromomycin
Article | Year |
---|---|
Validation of automated docking programs for docking and database screening against RNA drug targets.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Databases, Factual; Ligands; Models, Molecular; Nucleic Acid Conformation; Quantitative Structure-Activity Relationship; RNA; RNA, Ribosomal; Software | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Separate domains in GCN1 for binding protein kinase GCN2 and ribosomes are required for GCN2 activation in amino acid-starved cells.
Topics: Alanine; Alleles; Anti-Bacterial Agents; Arginine; Binding Sites; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Fungal Proteins; Genes, Dominant; Glutathione Transferase; Models, Biological; Paromomycin; Peptide Elongation Factors; Peptide Initiation Factors; Phenotype; Phosphorylation; Polyribosomes; Prokaryotic Initiation Factor-2; Protein Binding; Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Recombinant Fusion Proteins; Ribosomes; RNA, Transfer; Saccharomyces cerevisiae Proteins; Yeasts | 2000 |
Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Arginine; Cell Line; Cells, Cultured; Chemokine CCL5; Chemokine CXCL12; Chemokines, CXC; Drug Resistance, Viral; Framycetin; HIV Envelope Protein gp120; HIV-1; Humans; Leukocytes, Mononuclear; Neomycin; Paromomycin; Receptors, CXCR4; Structure-Activity Relationship; Virus Replication | 2003 |
Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Arginine; Binding Sites; Fluorescence Polarization; HIV-1; Molecular Structure; Neomycin; Nuclear Magnetic Resonance, Biomolecular; Paromomycin; RNA, Viral; Structure-Activity Relationship | 2004 |